|

Heart Disease Clinical Trials in Michigan

148 recruiting studies across 60 cities

All Trials in Michigan

Phase
Trial Phase Location
A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD StudyN/AAnn Arbor
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma—Ann Arbor
A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)Phase 1/2Ann Arbor
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsPhase 3Ann Arbor
A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM—Ann Arbor
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionPhase 3Ann Arbor
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic DysfunctionPhase 3Ann Arbor
ADAPT Micro-Randomized TrialN/AAnn Arbor
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary LesionsN/AAnn Arbor
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™N/AAnn Arbor
ATLAS (AltaValve) Pivotal TrialN/AAnn Arbor
ATrial Tachycardia PAcing Therapy in Congenital Heart—Ann Arbor
Abatacept in Immune Checkpoint Inhibitor MyocarditisPhase 3Ann Arbor
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic CardiomyopathyN/AAnn Arbor
Alleviant ALLAY-HF StudyN/AAnn Arbor
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPhase 3Ann Arbor
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Ann Arbor
Assessment of CCM in HF With Higher Ejection FractionN/AAnn Arbor
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker SystemN/AAnn Arbor
BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart DiseaseN/AAnn Arbor
BoxX-NoAF Clinical TrialN/AAnn Arbor
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic MaterialN/AAnn Arbor
CCM OPEN HF Registry—Ann Arbor
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)N/AAnn Arbor
Cardiac Sarcoidosis Randomized TrialPhase 3Ann Arbor
Cardiovascular Health Improvement Project—Ann Arbor
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial FibrillationN/AAnn Arbor
Cephea Early Feasibility StudyN/AAnn Arbor
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial FibrillationN/AAnn Arbor
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in WomenN/AAnn Arbor
Danon Disease Natural History Study—Ann Arbor
Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) ProgramN/AAnn Arbor
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart FailureN/AAnn Arbor
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical TrialN/AAnn Arbor
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina IIN/AAnn Arbor
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)Phase 2/3Ann Arbor
Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVADN/AAnn Arbor
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2Phase 3Ann Arbor
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyN/AAnn Arbor
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery OutcomesN/AAnn Arbor
HCMR Re-Imaging Study—Ann Arbor
Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyPhase 4Ann Arbor
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart FailureN/AAnn Arbor
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular RiskPhase 3Ann Arbor
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)Phase 3Ann Arbor
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityPhase 3Ann Arbor
Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic ScorePhase 4Ann Arbor
Medtronic Cardiac Surgery PMCF Registry—Ann Arbor
Mobile Health Intervention to Increase Activity in Heart Failure StudyN/AAnn Arbor
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease—Ann Arbor
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs—Ann Arbor
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)N/AAnn Arbor
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight InfantsN/AAnn Arbor
Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell TransplantationN/AAnn Arbor
Prenatally-initiated Psychological Intervention for Mothers of Infants With Congenital Heart Disease (CHD)N/AAnn Arbor
Prevail Global StudyN/AAnn Arbor
Product Surveillance Registry—Ann Arbor
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE—Ann Arbor
Reducing Risk for Infective EndocarditisN/AAnn Arbor
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3Ann Arbor
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailureN/AAnn Arbor
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 3Ann Arbor
TVMR With the INNOVALVE System Trial - Early Feasibility StudyN/AAnn Arbor
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac SurgeryPhase 4Ann Arbor
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRN/AAnn Arbor
The Fourth Left Atrial Appendage Occlusion StudyN/AAnn Arbor
The TRICURE EFS StudyN/AAnn Arbor
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)—Ann Arbor
Tracking Results of Ablations to Combat AF Registry Generation 2—Ann Arbor
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.N/AAnn Arbor
Valved Graft PMCF Study—Ann Arbor
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency DepartmentN/AAnn Arbor
Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3)Phase 2/3Arbor
Ask Questions About Clinical TrialsN/ABay City
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3Bay City
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityPhase 3Bloomfield Hills
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac EventsPhase 2Bloomfield Hills
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartPhase 3Bloomfield Hills
A Trial of CRD-4730 in HFrEFPhase 2Bloomfield Hills
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial FibrillationPhase 3Bloomfield Hills
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is UnsuitablePhase 3Bloomfield Hills
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailurePhase 3Dearborn
SuperSaturated Oxygen Comprehensive Observational Registry—Dearborn
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)N/ADetriot
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve StenosisPhase 2Detroit
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/ADetroit
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart DiseaseN/ADetroit
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular HypertrophyPhase 2Detroit
A Study of LY3971297 in Participants With Heart FailurePhase 1Detroit
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial FibrillationPhase 2Detroit
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor—Detroit
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic ValvesN/ADetroit
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart ValveN/ADetroit
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsPhase 3Detroit
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPhase 3Detroit
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)N/ADetroit
Central Apnea in Heart Failure: Physiological Mechanisms to Inform TreatmentPhase 4Detroit
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter DefibrillatorPhase 4Detroit
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—Detroit
Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device ImplantationN/ADetroit
IVUS CHIP UPP Registry—Detroit
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)N/ADetroit
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 3Detroit
PARTNER 3 Trial - Aortic Valve-in-ValveN/ADetroit
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive ProcedureN/ADetroit
Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)—Detroit
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)N/ADetroit
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR—Detroit
Project 4: ACHIEVE PATHFINDERN/ADetroit
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention—Detroit
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias—Detroit
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery LesionsN/ADetroit
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPhase 3Detroit
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With CardiomyopathyPhase 3Detroit
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) PatientsPhase 4Detroit
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial FibrillationPhase 3Detroit
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVRN/ADetroit
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureN/ADetroit
UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EFN/ADetroit
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High RiskPhase 3Farmington Hills
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinPhase 3Farmington Hills
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With AnticoagulationPhase 2Farmington Hills
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFPhase 3Flint
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)—Grand Rapids
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic CardiomyopathyPhase 2Grand Rapids
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry—Grand Rapids
AngelMed Guardian® System PMA Post Approval Study—Grand Rapids
Medtronic Terminate AF StudyN/AGrand Rapids
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and IIIN/AHowell
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Kalamazoo
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4Lansing
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products—Lansing
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve ReplacementN/ALansing
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)Phase 3Lansing
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.—Lansing
Lifewise Preventive Video Education in Primary CareN/ALivonia
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation—Michigan Center
Focused Orticumab Research for Treating Inflammation in Coronary ArteriesPhase 2Midland
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled StudyPhase 2/3Royal Oak
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.Phase 2Royal Oak
PULSED AF Post-Approval Study—Royal Oak
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVRN/ARoyal Oak
Virtue® SAB in the Treatment of Coronary ISR TrialN/ARoyal Oak
Minima Stent System Post- Approval Study (PAS)—Saint Louis
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter SystemN/AYpsilanti
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)Phase 2Ypsilanti
Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation ProgramsN/AYpsilanti
Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFA—Ypsilanti

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.